Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2026-05-27 Major Shareholding Noti…
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Lakefront Receives Transparency Notification from Bank of America
Major Shareholding Notification Classification · 95% confidence The document is a transparency notification under Belgian legislation regarding Bank of America’s crossing of the 5% voting rights threshold in Lakefront Biotherapeutics. It provides detailed tables of voting rights and financial instruments, matching the definition of a major shareholding notification.
2026-05-27 English
Lakefront Receives Transparency Notification from Bank of America
Major Shareholding Notification Classification · 90% confidence The document is a regulatory disclosure notifying that Bank of America crossed the 5% voting rights threshold in Lakefront Biotherapeutics, detailing the number of shares and equivalent instruments held. It falls squarely under the category for major shareholding notifications (notifications of changes in significant share ownership levels).
2026-05-27 Dutch
FORM 6-K
Regulatory Filings
2026-05-27 English
LAKEFRONT BIOTHERAPEUTICS NV Form TD 13.05.2026 Part I.pdf
Major Shareholding Notification Classification · 95% confidence The document is a Transparency Notification under the Belgian FSMA (Form TR-1 BE) disclosing changes in a parent undertaking’s voting rights and crossing a 5% threshold. It is a formal major shareholding notification. According to the category definitions, this corresponds to Major Shareholding Notification (Code: MRQ).
2026-05-26 English
LAKEFRONT BIOTHERAPEUTICS NV_Corp Structure_TD 13.05.2026.pdf
Regulatory Filings Classification · 30% confidence The document consists solely of corporate profile snapshots and legal/group structure diagrams (ownership charts for BofA Securities, Inc., Managed Account Advisors LLC, U.S. Trust Company of Delaware). It contains no meeting materials, financial statements, filings, or regulatory form content. It does not match any specific filing type definitions and serves as a general corporate information page. Therefore, it falls into the fallback category: Regulatory Filings (RNS).
2026-05-26 English
Lakefront Receives Transparency Notification from Bank of America.pdf
Major Shareholding Notification Classification · 95% confidence The document is a transparency notification under Belgian legislation indicating that Bank of America crossed above the 5% voting rights threshold in Lakefront Biotherapeutics. It reports detailed holdings and instrument breakdown to satisfy major shareholding disclosure requirements. This matches the definition of a Major Shareholding Notification (MRQ).
2026-05-26 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.